Literature DB >> 25934009

From evidence to clinical practice in blood and marrow transplantation.

Nandita Khera1.   

Abstract

Clinical practice in the field of blood and marrow transplantation (BMT) has evolved over time, as a result of thousands of basic and clinical research studies. While it appears that scientific discovery and adaptive clinical research may be well integrated in case of BMT, there is lack of sufficient literature to definitively understand the process of translation of evidence to practice and if it may be selective . In this review, examples from BMT and other areas of medicine are used to highlight the state of and potential barriers to evidence uptake. Strategies to help improve knowledge transfer are discussed and the role of existing framework provided by the Center for International Blood and Marrow Transplant Registry (CIBMTR) to monitor uptake and BMT Clinical Trials Network (BMT CTN) to enhance translation of evidence into practice is highlighted.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood and marrow transplantation; Clinical trials; Dissemination and implementation research; Evidence uptake; Practice patterns

Mesh:

Year:  2015        PMID: 25934009      PMCID: PMC4610823          DOI: 10.1016/j.blre.2015.04.001

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  49 in total

1.  Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients.

Authors:  Neena S Abraham; Christine Hartman; Peter Richardson; Diana Castillo; Richard L Street; Aanand D Naik
Journal:  Circulation       Date:  2013-09-11       Impact factor: 29.690

2.  Use of the quality management system "JACIE" and outcome after hematopoietic stem cell transplantation.

Authors:  Alois Gratwohl; Ronald Brand; Eoin McGrath; Anja van Biezen; Anna Sureda; Per Ljungman; Helen Baldomero; Christian Chabannon; Jane Apperley
Journal:  Haematologica       Date:  2014-01-31       Impact factor: 9.941

3.  Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.

Authors:  Amrita Krishnan; Marcelo C Pasquini; Brent Logan; Edward A Stadtmauer; David H Vesole; Edwin Alyea; Joseph H Antin; Raymond Comenzo; Stacey Goodman; Parameswaran Hari; Ginna Laport; Muzaffar H Qazilbash; Scott Rowley; Firoozeh Sahebi; George Somlo; Dan T Vogl; Daniel Weisdorf; Marian Ewell; Juan Wu; Nancy L Geller; Mary M Horowitz; Sergio Giralt; David G Maloney
Journal:  Lancet Oncol       Date:  2011-09-29       Impact factor: 41.316

4.  Abandonment of high-dose chemotherapy/hematopoietic cell transplants for breast cancer following negative trial results.

Authors:  David H Howard; Carolyn Kenline; Hillard M Lazarus; Charles F Lemaistre; Richard T Maziarz; Philip L McCarthy; Susan K Parsons; David Szwajcer; James Douglas Rizzo; Navneet S Majhail
Journal:  Health Serv Res       Date:  2011-07-25       Impact factor: 3.402

5.  One-unit versus two-unit cord-blood transplantation for hematologic cancers.

Authors:  John E Wagner; Mary Eapen; Shelly Carter; Yanli Wang; Kirk R Schultz; Donna A Wall; Nancy Bunin; Colleen Delaney; Paul Haut; David Margolis; Edward Peres; Michael R Verneris; Mark Walters; Mary M Horowitz; Joanne Kurtzberg
Journal:  N Engl J Med       Date:  2014-10-30       Impact factor: 91.245

6.  Peripheral-blood stem cells versus bone marrow from unrelated donors.

Authors:  Claudio Anasetti; Brent R Logan; Stephanie J Lee; Edmund K Waller; Daniel J Weisdorf; John R Wingard; Corey S Cutler; Peter Westervelt; Ann Woolfrey; Stephen Couban; Gerhard Ehninger; Laura Johnston; Richard T Maziarz; Michael A Pulsipher; David L Porter; Shin Mineishi; John M McCarty; Shakila P Khan; Paolo Anderlini; William I Bensinger; Susan F Leitman; Scott D Rowley; Christopher Bredeson; Shelly L Carter; Mary M Horowitz; Dennis L Confer
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

7.  Comparison of survival outcomes among cancer patients treated in and out of clinical trials.

Authors:  Joseph M Unger; William E Barlow; Diane P Martin; Scott D Ramsey; Michael Leblanc; Ruth Etzioni; Dawn L Hershman
Journal:  J Natl Cancer Inst       Date:  2014-03-13       Impact factor: 13.506

8.  External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer.

Authors:  Willemien van de Water; Mandy Kiderlen; Esther Bastiaannet; Sabine Siesling; Rudi G J Westendorp; Cornelis J H van de Velde; Johan W R Nortier; Caroline Seynaeve; Anton J M de Craen; Gerrit-Jan Liefers
Journal:  J Natl Cancer Inst       Date:  2014-03-19       Impact factor: 13.506

9.  Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.

Authors:  Michel Attal; Valerie Lauwers-Cances; Gerald Marit; Denis Caillot; Philippe Moreau; Thierry Facon; Anne Marie Stoppa; Cyrille Hulin; Lofti Benboubker; Laurent Garderet; Olivier Decaux; Serge Leyvraz; Marie-Christiane Vekemans; Laurent Voillat; Mauricette Michallet; Brigitte Pegourie; Charles Dumontet; Murielle Roussel; Xavier Leleu; Claire Mathiot; Catherine Payen; Hervé Avet-Loiseau; Jean-Luc Harousseau
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245

10.  Lenalidomide after stem-cell transplantation for multiple myeloma.

Authors:  Philip L McCarthy; Kouros Owzar; Craig C Hofmeister; David D Hurd; Hani Hassoun; Paul G Richardson; Sergio Giralt; Edward A Stadtmauer; Daniel J Weisdorf; Ravi Vij; Jan S Moreb; Natalie Scott Callander; Koen Van Besien; Teresa Gentile; Luis Isola; Richard T Maziarz; Don A Gabriel; Asad Bashey; Heather Landau; Thomas Martin; Muzaffar H Qazilbash; Denise Levitan; Brian McClune; Robert Schlossman; Vera Hars; John Postiglione; Chen Jiang; Elizabeth Bennett; Susan Barry; Linda Bressler; Michael Kelly; Michele Seiler; Cara Rosenbaum; Parameswaran Hari; Marcelo C Pasquini; Mary M Horowitz; Thomas C Shea; Steven M Devine; Kenneth C Anderson; Charles Linker
Journal:  N Engl J Med       Date:  2012-05-10       Impact factor: 91.245

View more
  3 in total

Review 1.  Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committee.

Authors:  Akshay Sharma; Sherif M Badawy; Elizabeth M Suelzer; Hemant S Murthy; Pinki Prasad; Hesham Eissa; Paul A Carpenter; Mehdi Hamadani; Myriam Labopin; Hélène Schoemans; André Tichelli; Rachel Phelan; Betty K Hamilton; David Buchbinder; Annie Im; Rebecca Hunter; Ruta Brazauskas; Linda J Burns
Journal:  Bone Marrow Transplant       Date:  2021-01-29       Impact factor: 5.483

2.  A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703.

Authors:  Zachariah DeFilipp; Linda J Burns; Samantha M Jaglowski; Aaron L Leppin; Steven Pavletic; Bryce Waldman; Daniel J Weisdorf; William A Wood; Nandita Khera
Journal:  Biol Blood Marrow Transplant       Date:  2020-09-10       Impact factor: 5.742

3.  Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working Committee.

Authors:  Akshay Sharma; Sherif M Badawy; Elizabeth M Suelzer; Hemant S Murthy; Pinki Prasad; Hesham Eissa; Paul A Carpenter; Mehdi Hamadani; Myriam Labopin; Hélène Schoemans; André Tichelli; Rachel Phelan; Betty K Hamilton; David Buchbinder; Annie Im; Rebecca Hunter; Ruta Brazauskas; Linda J Burns
Journal:  Transplant Cell Ther       Date:  2021-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.